Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. vaccine quality and efficacy
Show results for
Articles

Refine by
Date

  • Older

Vaccine Quality And Efficacy Articles & Analysis: Older

25 articles found

Advanced Purification Techniques for Enhancing Vaccine Efficacy and Safety   

Advanced Purification Techniques for Enhancing Vaccine Efficacy and Safety  

Vaccines have been essential in disease prevention, and the requirements for vaccine quality continue to increase. The application of advanced separation and purification technologies during the preparation of traditional and new vaccines is an effective means to improve vaccine efficacy and ...

ByCreative Proteomics


Enzymes in mRNA Vaccine Manufacturing: A Cornerstone of Modern Medicine

Enzymes in mRNA Vaccine Manufacturing: A Cornerstone of Modern Medicine

The advent of mRNA vaccines has revolutionized the field of immunization, offering a rapid and adaptable response to emerging infectious diseases. ...

ByCreative Enzymes


Advanced Purification Techniques for Enhancing Vaccine Quality and Efficacy

Advanced Purification Techniques for Enhancing Vaccine Quality and Efficacy

Vaccines have been essential in disease prevention, and the requirements for vaccine quality continue to increase. The application of advanced separation and purification technologies during the preparation of traditional and new vaccines is an effective means to improve vaccine efficacy and ...

ByCreative Proteomics


Enhancing Efficacy: Unraveling the Potential of Adjuvants in mRNA Vaccines

Enhancing Efficacy: Unraveling the Potential of Adjuvants in mRNA Vaccines

In recent years, mRNA vaccines have emerged as a revolutionary tool in the fight against infectious diseases, including the ongoing COVID-19 pandemic. These vaccines utilize messenger RNA (mRNA) to instruct cells to produce a protein that triggers an immune response, leading to the production of antibodies that protect against the targeted virus. While mRNA vaccines have shown remarkable efficacy ...

ByBOC Sciences


A Milestone in Global Health: A New Polio Vaccine Approved for Emergency Use

A Milestone in Global Health: A New Polio Vaccine Approved for Emergency Use

In a significant stride towards eradicating a debilitating disease, a new polio vaccine has achieved WHO prequalification. This development represents a crucial milestone in global health, where effective vaccination remains our strongest defence. With a novel design intended to tackle a persistent challenge of the virus, this vaccine is poised to bolster our fight against the spread of ...

ByB Medical Systems


Revolutionizing the fight against Ebola

Revolutionizing the fight against Ebola

Introduction In the ongoing battle against infectious diseases, Ebola stands out as one of the most daunting challenges the global health community has faced in recent decades. Characterized by its high fatality rates and rapid transmission, the Ebola virus has historically plunged entire regions into states of emergency. However, groundbreaking advancements in vaccine development promise not ...

ByB Medical Systems


Research Progress on Aluminum Adjuvants and Their Mechanisms of Action

Research Progress on Aluminum Adjuvants and Their Mechanisms of Action

Adjuvants can help antigens induce long-term effective specific immune responses in vivo, leading to higher vaccine efficacy and prolonged protection from immune responses. Adjuvants can also reduce the amount of antigen used, the cost of production and the number of immunizations. ...

ByBOC Sciences


Strengthening Cold Chain Systems in Thailand and Beyond: Part 2

Strengthening Cold Chain Systems in Thailand and Beyond: Part 2

Quality containers ensure that vaccines remain at the required temperature, preventing any degradation in their efficacy. ...

ByB Medical Systems


The Significance of Raw Enzymes in the Success of mRNA Vaccines

The Significance of Raw Enzymes in the Success of mRNA Vaccines

Raw enzymes orchestrate these modifications with precision, ensuring that the mRNA is well-prepared for its crucial role in vaccine production. Quality Assurance: The road to a successful mRNA vaccine is paved with quality control measures. ...

ByCreative Enzymes


Breaking Barriers: Harnessing the Potential of Adjuvants in Vaccine Development

Breaking Barriers: Harnessing the Potential of Adjuvants in Vaccine Development

Infectious diseases seriously threaten human health, and various infectious diseases may cause millions of severe cases and even death every year. Vaccination has been one of the most effective public health interventions in history, preventing millions of deaths worldwide. However, the success of vaccines relies not only on the antigens they carry but also on additional components known as ...

ByAlfa Chemistry


Why promising malaria vaccines need a modern cold chain

Why promising malaria vaccines need a modern cold chain

Each year malaria kills hundreds of thousands of people – mostly children – around the globe, and according to a report by the WHO, in 2021 nearly half of the world’s population was at risk of malaria. This included infants, children under 5 years of age, pregnant women, patients with HIV/AIDS, etc. Moreover, over the two peak years of the pandemic, COVID-related disruptions ...

ByB Medical Systems


FluGen Announces Completion of First Cohort in Age De-escalation Clinical Trial of M2SR Flu Vaccine Candidate in Pediatric Subjects Ages 6 Months to 17 Years

FluGen Announces Completion of First Cohort in Age De-escalation Clinical Trial of M2SR Flu Vaccine Candidate in Pediatric Subjects Ages 6 Months to 17 Years

MADISON, Wis., Sept. 7, 2022 /PRNewswire/ — FluGen, Inc., a clinical-stage vaccine company transforming vaccine efficacy in infectious respiratory diseases, today announced the completion of enrollment of the first cohort in an age de-escalation clinical trial of M2SR (M2 Deficient Single Replication) live virus vaccine, the company’s investigational supra-seasonal intranasal ...

ByFluGen, Inc.


FluGen Announces First Subject Dosed in Phase 1b Clinical Trial of its Intranasal M2SR Flu Vaccine, Co-Administered with High Dose Vaccine, in Older Adults

FluGen Announces First Subject Dosed in Phase 1b Clinical Trial of its Intranasal M2SR Flu Vaccine, Co-Administered with High Dose Vaccine, in Older Adults

Study will measure immune responses generated by M2SR and high dose vaccine separately and in combination in the highly vulnerable 65-85 years old population – Funded by the US Department of Defense, this study is expected to yield topline data in 2H 2022 – MADISON, Wis., June 22, 2022 /PRNewswire/ — FluGen, Inc., a clinical-stage vaccine company transforming vaccine ...

ByFluGen, Inc.


Vaccine Acceptance and Why Storage Matters

Vaccine Acceptance and Why Storage Matters

Factors Leading to Vaccine Hesitancy Since the first vaccine was developed in 1798 against smallpox, there have been people who were in favor of vaccinations, those who were against it, and those who were unsure. ...

ByB Medical Systems


FluGen Announces Publication of Positive Results from Phase 2 Human Challenge Study of Its M2SR Vaccine Candidate Against Highly Drifted Strain of H3N2 Influenza Virus

FluGen Announces Publication of Positive Results from Phase 2 Human Challenge Study of Its M2SR Vaccine Candidate Against Highly Drifted Strain of H3N2 Influenza Virus

Data published in the Journal of Infectious Diseases demonstrate that M2SR can protect against a multi-seasonal, seven-year drifted influenza strain – MADISON, Wis., Aug. 2, 2021 /PRNewswire/ — FluGen, Inc., a clinical-stage vaccine company transforming vaccine efficacy in infectious respiratory diseases, today announced the publication of results from its Phase 2 human challenge ...

ByFluGen, Inc.


Coronavirus Variants: The Delta Variant and the Future Impact of Viral Mutations

Coronavirus Variants: The Delta Variant and the Future Impact of Viral Mutations

If you are fully vaccinated, should you be worried about the impact of COVID-19 variants? No, in fact vaccines have been shown to be highly effective at preventing hospitalizations and deaths from these SARS-CoV-2 variants. While the infamous Delta variant has now been detected in 98 countries and all 50 states, 99% of all COVID-19 deaths and hospitalization cases are unvaccinated, according to ...

ByChemical Abstracts Service (CAS)


FluGen Awarded US Department of Defense Funding to Conduct Clinical Study Evaluating Investigational M2SR Flu Vaccine and Current Standard-of-Care High Dose Vaccine

FluGen Awarded US Department of Defense Funding to Conduct Clinical Study Evaluating Investigational M2SR Flu Vaccine and Current Standard-of-Care High Dose Vaccine

Study is the Company’s first trial evaluating ability of M2SR and the current licensed standard of care to protect against drifted virus strains, and its second study in older adults, a population most vulnerable to mortality from flu – Safety and immunogenicity study expected to begin in Q2 2022 – MADISON, Wis., July 1, 2021 /PRNewswire/ — FluGen, Inc., a clinical-stage ...

ByFluGen, Inc.


FluGen Initiates NIH-Funded Trial of M2SR Flu Vaccine; First Study in Adults Up to Age 85

FluGen Initiates NIH-Funded Trial of M2SR Flu Vaccine; First Study in Adults Up to Age 85

Study will measure immune responses to matched and drifted virus strains in older adults, a population that is most vulnerable to mortality from flu – Topline data expected in 1H 2022 – MADISON, Wis., May 25, 2021 /PRNewswire/ — FluGen, Inc., a clinical-stage vaccine company transforming vaccine efficacy in infectious respiratory diseases, today announced the initiation of the ...

ByFluGen, Inc.


Latest data on the safety and effectiveness of COVID-19 vaccines in children

Latest data on the safety and effectiveness of COVID-19 vaccines in children

Childhood vaccinations provide immunity to children against serious infectious diseases before they are exposed to them to prevent illness. Many childhood diseases, such as smallpox and polio, have been almost completely eradicated as a result of widespread, standardized childhood vaccination programs. Some vaccinations, such as those for highly contagious diseases including measles, mumps, ...

ByChemical Abstracts Service (CAS)


The Future of COVID-19 and Vaccinations

The Future of COVID-19 and Vaccinations

Coronavirus 2021 COVID-19 is nearing the one-year mark in the United States with over 26.2 million cases to date. While cases in the United States are still doubling their daily totals, many people worldwide are experiencing pandemic fatigue. Just before the end of 2020, companies like Moderna and Pfizer, with help from many C & A Scientific customers, were able to provide a solution ...

ByC&A Scientific

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT